Advertisement
News
Advertisement

Developing Cancer Drugs Based on Genomics

Mon, 04/18/2011 - 9:38pm
Massachusetts Institute of Technology

Blueprint Medicines, a startup based in Cambridge, Massachusetts, plans to use the growing amount of genomic information about cancer to create new drugs targeted at the mechanisms that drive specific subtypes of the disease. The company, which announced its creation last week with $40 million in funding from Third Rock Ventures, reflects a growing trend toward defining cancers not by their location in the body but by the particular collections of genetic mistakes that enable tumor cells to grow out of control.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading